Search results
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
GuruFocus.com via Yahoo Finance· 3 months agoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a fast-growing pharmaceutical company focused on the...
What to Know About Hunter Syndrome (MPS II)
Verywell Health via Yahoo News· 11 months agoThis Rare Genetic Condition Mostly Affects Males tatyana_tomsickova / Getty Images Medically reviewed by Jonathan B. Jassey, DO Hunter syndrome aka...
Ultragenyx's (RARE) Preliminary 2023 Revenues Disappoint
Zacks via Yahoo Finance· 5 months agoUltragenyx Pharmaceutical RARE reported preliminary total revenues (unaudited) of $430-$435 million...
Most babies with this rare genetic disease are on ventilators by 8 months. This Austin baby beat the...
Austin American-Statesman via Yahoo News· 2 years agoNoah Strauch loves to laugh. He loves to put things into a bucket and dump them out again. He crawls...
Why Orchard Therapeutics Stock Is Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoOrchard Therapeutics Inc (NASDAQ: ORTX) announced multiple clinical and preclinical updates from its...
Ultragenyx (RARE) Q1 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 1 year agoUltragenyx Pharmaceutical Inc. RARE incurred a loss of $2.33 per share in first-quarter 2023, wider...
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo Finance· 8 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...
GuruFocus.com via Yahoo Finance· 1 month agoTotal Revenue: Reported $109 million in Q1 2024, an 8% increase year-over-year, falling short of the...
Is Ultragenyx Pharmaceutical (RARE) Too Good to Be True? A Comprehensive Analysis of a ...
GuruFocus.com via Yahoo Finance· 9 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
Biotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More
Zacks via Yahoo Finance· 4 months agoIt has been a busy week for the biotech sector, with earnings from bigwigs like Gilead Sciences...